Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis

Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis

Background: There are several serological tests used in the diagnosis of melioidosis. However, the interpretation of the results can be problematic in endemic areas because there might be a high background positivity due to previous exposure. Objective: This study aimed to determine the usefulness o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bangladesh journal of infectious diseases 2020-01, Vol.7 (2), p.61-66
Hauptverfasser: Arumugam Janaki, How, Soon Hin, Zainulabid, Ummu Afeera, Mohammed Imad A Mustafa Mahmud, Jamaluddin Ab Rahman, Ahmad Kashfi Ab Rahman, Yeh Chunn Kuan
Format: Artikel
Sprache:eng
Schlagworte:
Serology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 66
container_issue 2
container_start_page 61
container_title Bangladesh journal of infectious diseases
container_volume 7
creator Arumugam Janaki
How, Soon Hin
Zainulabid, Ummu Afeera
Mohammed Imad A Mustafa Mahmud
Jamaluddin Ab Rahman
Ahmad Kashfi Ab Rahman
Yeh Chunn Kuan
description Background: There are several serological tests used in the diagnosis of melioidosis. However, the interpretation of the results can be problematic in endemic areas because there might be a high background positivity due to previous exposure. Objective: This study aimed to determine the usefulness of Indirect Immunofluorescent Antibody (IFA) IgM and IgG in the diagnosis of melioidosis and the time for seroconversion. Methodology: We prospectively studied the trend of IFA IgM and IgG in 40 patients with culture-confirmed melioidosis over three months at six different time points (days 1, 8, 15, 30, 60, and 90). Results: From the results, 37.5% and 32.5% of patients had IFA IgM and IgG of ≤ 1:20 respectively on day 1 when the blood culture was positive. The natural log (ln) of the titres was used for the analysis. Repeated measures ANOVA showed significant changes in both IgM (p= 0.001) and IgG (p= 0.045) respectively throughout six sampling time points. Both the means of ln IgM and ln IgG peaked at day 15. At day 90, mean ln IgG remained high but mean ln IgM dropped to a level below that of day one. All culture-confirmed melioidosis patients recorded a maximum IFA IgM titre of at least 1: 80, but all subsequently dropped to below this level at day 90. Conclusion: IFA IgM is a more useful diagnostic serological marker than IFA IgG in acute melioidosis. Bangladesh Journal of Infectious Diseases 2020;7(2):61-66
doi_str_mv 10.3329/bjid.v7i2.51514
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2830601204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489084001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1424-4c2417397a477f7e9028324c4e2a82cc9cac339e6ecc085d68f44ba4e763b06b3</originalsourceid><addsrcrecordid>eNp9kMFLwzAUxoMoOObOXgOeu70kb017HENnwaGggreQpqlkbMlM2sH-ezu3s6fvHX583-NHyD2DqRC8nNUb10wP0vHpnM0ZXpERR8ayXMLX9eXGgsMtmaS0AQAumJDARuTt3cZggj_YmFzwNLS08o2L1nS02u16H9ptH6JNxvqOLnzn6tAcafW9pto3Q66o83Rtty64JiSX7shNq7fJTi45Jp9Pjx_L5-zldVUtFy-ZYcgxQzM8JUUpNUrZSlsCLwRHg5brghtTGm2EKG1ujYFi3uRFi1hrtDIXNeS1GJOHc-8-hp_epk5tQh_9MKmGJsiBccB_KSxKKBCADdTsTJkYUoq2VfvodjoeFQN18qtOftXJr_rzK34BMDNthA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489084001</pqid></control><display><type>article</type><title>Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Arumugam Janaki ; How, Soon Hin ; Zainulabid, Ummu Afeera ; Mohammed Imad A Mustafa Mahmud ; Jamaluddin Ab Rahman ; Ahmad Kashfi Ab Rahman ; Yeh Chunn Kuan</creator><creatorcontrib>Arumugam Janaki ; How, Soon Hin ; Zainulabid, Ummu Afeera ; Mohammed Imad A Mustafa Mahmud ; Jamaluddin Ab Rahman ; Ahmad Kashfi Ab Rahman ; Yeh Chunn Kuan</creatorcontrib><description>Background: There are several serological tests used in the diagnosis of melioidosis. However, the interpretation of the results can be problematic in endemic areas because there might be a high background positivity due to previous exposure. Objective: This study aimed to determine the usefulness of Indirect Immunofluorescent Antibody (IFA) IgM and IgG in the diagnosis of melioidosis and the time for seroconversion. Methodology: We prospectively studied the trend of IFA IgM and IgG in 40 patients with culture-confirmed melioidosis over three months at six different time points (days 1, 8, 15, 30, 60, and 90). Results: From the results, 37.5% and 32.5% of patients had IFA IgM and IgG of ≤ 1:20 respectively on day 1 when the blood culture was positive. The natural log (ln) of the titres was used for the analysis. Repeated measures ANOVA showed significant changes in both IgM (p= 0.001) and IgG (p= 0.045) respectively throughout six sampling time points. Both the means of ln IgM and ln IgG peaked at day 15. At day 90, mean ln IgG remained high but mean ln IgM dropped to a level below that of day one. All culture-confirmed melioidosis patients recorded a maximum IFA IgM titre of at least 1: 80, but all subsequently dropped to below this level at day 90. Conclusion: IFA IgM is a more useful diagnostic serological marker than IFA IgG in acute melioidosis. Bangladesh Journal of Infectious Diseases 2020;7(2):61-66</description><identifier>ISSN: 2411-4820</identifier><identifier>EISSN: 2411-670X</identifier><identifier>DOI: 10.3329/bjid.v7i2.51514</identifier><language>eng</language><publisher>Dhaka: National Institute of Neurosciences &amp; Hospital</publisher><subject>Serology</subject><ispartof>Bangladesh journal of infectious diseases, 2020-01, Vol.7 (2), p.61-66</ispartof><rights>2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1424-4c2417397a477f7e9028324c4e2a82cc9cac339e6ecc085d68f44ba4e763b06b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Arumugam Janaki</creatorcontrib><creatorcontrib>How, Soon Hin</creatorcontrib><creatorcontrib>Zainulabid, Ummu Afeera</creatorcontrib><creatorcontrib>Mohammed Imad A Mustafa Mahmud</creatorcontrib><creatorcontrib>Jamaluddin Ab Rahman</creatorcontrib><creatorcontrib>Ahmad Kashfi Ab Rahman</creatorcontrib><creatorcontrib>Yeh Chunn Kuan</creatorcontrib><title>Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis</title><title>Bangladesh journal of infectious diseases</title><description>Background: There are several serological tests used in the diagnosis of melioidosis. However, the interpretation of the results can be problematic in endemic areas because there might be a high background positivity due to previous exposure. Objective: This study aimed to determine the usefulness of Indirect Immunofluorescent Antibody (IFA) IgM and IgG in the diagnosis of melioidosis and the time for seroconversion. Methodology: We prospectively studied the trend of IFA IgM and IgG in 40 patients with culture-confirmed melioidosis over three months at six different time points (days 1, 8, 15, 30, 60, and 90). Results: From the results, 37.5% and 32.5% of patients had IFA IgM and IgG of ≤ 1:20 respectively on day 1 when the blood culture was positive. The natural log (ln) of the titres was used for the analysis. Repeated measures ANOVA showed significant changes in both IgM (p= 0.001) and IgG (p= 0.045) respectively throughout six sampling time points. Both the means of ln IgM and ln IgG peaked at day 15. At day 90, mean ln IgG remained high but mean ln IgM dropped to a level below that of day one. All culture-confirmed melioidosis patients recorded a maximum IFA IgM titre of at least 1: 80, but all subsequently dropped to below this level at day 90. Conclusion: IFA IgM is a more useful diagnostic serological marker than IFA IgG in acute melioidosis. Bangladesh Journal of Infectious Diseases 2020;7(2):61-66</description><subject>Serology</subject><issn>2411-4820</issn><issn>2411-670X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kMFLwzAUxoMoOObOXgOeu70kb017HENnwaGggreQpqlkbMlM2sH-ezu3s6fvHX583-NHyD2DqRC8nNUb10wP0vHpnM0ZXpERR8ayXMLX9eXGgsMtmaS0AQAumJDARuTt3cZggj_YmFzwNLS08o2L1nS02u16H9ptH6JNxvqOLnzn6tAcafW9pto3Q66o83Rtty64JiSX7shNq7fJTi45Jp9Pjx_L5-zldVUtFy-ZYcgxQzM8JUUpNUrZSlsCLwRHg5brghtTGm2EKG1ujYFi3uRFi1hrtDIXNeS1GJOHc-8-hp_epk5tQh_9MKmGJsiBccB_KSxKKBCADdTsTJkYUoq2VfvodjoeFQN18qtOftXJr_rzK34BMDNthA</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Arumugam Janaki</creator><creator>How, Soon Hin</creator><creator>Zainulabid, Ummu Afeera</creator><creator>Mohammed Imad A Mustafa Mahmud</creator><creator>Jamaluddin Ab Rahman</creator><creator>Ahmad Kashfi Ab Rahman</creator><creator>Yeh Chunn Kuan</creator><general>National Institute of Neurosciences &amp; Hospital</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200101</creationdate><title>Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis</title><author>Arumugam Janaki ; How, Soon Hin ; Zainulabid, Ummu Afeera ; Mohammed Imad A Mustafa Mahmud ; Jamaluddin Ab Rahman ; Ahmad Kashfi Ab Rahman ; Yeh Chunn Kuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1424-4c2417397a477f7e9028324c4e2a82cc9cac339e6ecc085d68f44ba4e763b06b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Serology</topic><toplevel>online_resources</toplevel><creatorcontrib>Arumugam Janaki</creatorcontrib><creatorcontrib>How, Soon Hin</creatorcontrib><creatorcontrib>Zainulabid, Ummu Afeera</creatorcontrib><creatorcontrib>Mohammed Imad A Mustafa Mahmud</creatorcontrib><creatorcontrib>Jamaluddin Ab Rahman</creatorcontrib><creatorcontrib>Ahmad Kashfi Ab Rahman</creatorcontrib><creatorcontrib>Yeh Chunn Kuan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Bangladesh journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arumugam Janaki</au><au>How, Soon Hin</au><au>Zainulabid, Ummu Afeera</au><au>Mohammed Imad A Mustafa Mahmud</au><au>Jamaluddin Ab Rahman</au><au>Ahmad Kashfi Ab Rahman</au><au>Yeh Chunn Kuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis</atitle><jtitle>Bangladesh journal of infectious diseases</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>7</volume><issue>2</issue><spage>61</spage><epage>66</epage><pages>61-66</pages><issn>2411-4820</issn><eissn>2411-670X</eissn><abstract>Background: There are several serological tests used in the diagnosis of melioidosis. However, the interpretation of the results can be problematic in endemic areas because there might be a high background positivity due to previous exposure. Objective: This study aimed to determine the usefulness of Indirect Immunofluorescent Antibody (IFA) IgM and IgG in the diagnosis of melioidosis and the time for seroconversion. Methodology: We prospectively studied the trend of IFA IgM and IgG in 40 patients with culture-confirmed melioidosis over three months at six different time points (days 1, 8, 15, 30, 60, and 90). Results: From the results, 37.5% and 32.5% of patients had IFA IgM and IgG of ≤ 1:20 respectively on day 1 when the blood culture was positive. The natural log (ln) of the titres was used for the analysis. Repeated measures ANOVA showed significant changes in both IgM (p= 0.001) and IgG (p= 0.045) respectively throughout six sampling time points. Both the means of ln IgM and ln IgG peaked at day 15. At day 90, mean ln IgG remained high but mean ln IgM dropped to a level below that of day one. All culture-confirmed melioidosis patients recorded a maximum IFA IgM titre of at least 1: 80, but all subsequently dropped to below this level at day 90. Conclusion: IFA IgM is a more useful diagnostic serological marker than IFA IgG in acute melioidosis. Bangladesh Journal of Infectious Diseases 2020;7(2):61-66</abstract><cop>Dhaka</cop><pub>National Institute of Neurosciences &amp; Hospital</pub><doi>10.3329/bjid.v7i2.51514</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2411-4820
ispartof Bangladesh journal of infectious diseases, 2020-01, Vol.7 (2), p.61-66
issn 2411-4820
2411-670X
language eng
recordid cdi_proquest_journals_2830601204
source EZB-FREE-00999 freely available EZB journals
subjects Serology
title Seroconversion of Indirect Immunofluorescent Antibody IgM and IgG in Melioidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A18%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroconversion%20of%20Indirect%20Immunofluorescent%20Antibody%20IgM%20and%20IgG%20in%20Melioidosis&rft.jtitle=Bangladesh%20journal%20of%20infectious%20diseases&rft.au=Arumugam%20Janaki&rft.date=2020-01-01&rft.volume=7&rft.issue=2&rft.spage=61&rft.epage=66&rft.pages=61-66&rft.issn=2411-4820&rft.eissn=2411-670X&rft_id=info:doi/10.3329/bjid.v7i2.51514&rft_dat=%3Cproquest_cross%3E2489084001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489084001&rft_id=info:pmid/&rfr_iscdi=true